Literature DB >> 8890826

Frequency-dependent electrophysiologic properties of ventricular repolarization in patients with congenital long QT syndrome.

H Hirao1, W Shimizu, T Kurita, K Suyama, N Aihara, S Kamakura, K Shimomura.   

Abstract

OBJECTIVES: This study was performed to evaluate the frequency dependency of ventricular repolarization and the effect of epinephrine in patients with congenital long QT syndrome (LQTS).
BACKGROUND: The efficacy of pacemakers in addition to antiadrenergic therapy in the treatment of congenital LQTS has been reported.
METHODS: Monophasic action potentials were recorded from right and left ventricular endocardium during atrial pacing at heart rates from 70 to 140 beats/min at baseline and from 100 to 140 beats/min during epinephrine infusion (0.1 microgram/kg body weight per min) in 11 patients with congenital LQTS and 10 control patients. The response of monophasic action potential duration at 90% repolarization (MAPD90) and the dispersion of MAPD90 were examined.
RESULTS: At baseline, both the MAPD90 and the dispersion of MAPD90 were significantly (p < 0.001) longer in the congenital LQTS group than the control group. The differences in these variables between the two groups significantly decreased (MAPD90: from 105 to 31 ms; dispersion of MAPD90: from 55 to 13 ms, p < 0.001) at heart rate was increased. Epinephrine prolonged the MAPD90 and increased the dispersion of MAPD90 significantly (p < 0.001) at all paced heart rates in the congenital LQTS group without frequency dependency but did not change in the control group. Thus, epinephrine increased the differences in these variables between the two groups.
CONCLUSIONS: The repolarization abnormalities in congenital LQTS were attenuated by increasing the heart rate, which supported the efficacy of pacemaker therapy. However, during sympathetic stimulation, the effects of increased heart rate on these repolarization abnormalities were limited.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8890826     DOI: 10.1016/S0735-1097(96)00313-0

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  6 in total

Review 1.  Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome.

Authors:  M D Drici; N Clément
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 2.  Specific therapy based on the genotype and cellular mechanism in inherited cardiac arrhythmias. Long QT syndrome and Brugada syndrome.

Authors:  Wataru Shimizu; Takeshi Aiba; Charles Antzelevitch
Journal:  Curr Pharm Des       Date:  2005       Impact factor: 3.116

3.  Dispersion of regional wall motion abnormality in patients with long QT syndrome.

Authors:  K Nakayama; H Yamanari; F Otsuka; K Fukushima; H Saito; Y Fujimoto; T Emori; H Matsubara; S Uchida; T Ohe
Journal:  Heart       Date:  1998-09       Impact factor: 5.994

Review 4.  Pharmacological approach to the treatment of long and short QT syndromes.

Authors:  Chinmay Patel; Charles Antzelevitch
Journal:  Pharmacol Ther       Date:  2008-04       Impact factor: 12.310

5.  Maximal Exercise-Corrected QT as a Predictor of Coronary Artery Disease: Comparison of Simpler Heart Rate Corrections.

Authors:  Aydın Akyuz; Seref Alpsoy; Dursun Cayan Akkoyun; Hasan Degirmenci; Niyazi Guler
Journal:  Korean Circ J       Date:  2013-10-30       Impact factor: 3.243

Review 6.  Diagnosing Torsades De Pointes Based on Correlation to QT Interval: A Systematic Review.

Authors:  Simranjit S Kahlon; Rabia Sikandar; Sreedevi Tejovath; Shaalina Nair; Danial Hassan; Khushbu K Patel; Aishwarya Peddemul; Jihan A Mostafa
Journal:  Cureus       Date:  2022-08-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.